DE BELLIS, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 282
NA - Nord America 205
AS - Asia 122
SA - Sud America 38
AF - Africa 2
OC - Oceania 1
Totale 650
Nazione #
US - Stati Uniti d'America 200
IT - Italia 127
RU - Federazione Russa 68
SG - Singapore 57
BR - Brasile 35
DE - Germania 32
HK - Hong Kong 19
VN - Vietnam 18
FI - Finlandia 17
CN - Cina 10
CZ - Repubblica Ceca 10
IE - Irlanda 10
IN - India 8
CA - Canada 5
AT - Austria 4
KR - Corea 4
NL - Olanda 4
SE - Svezia 3
BD - Bangladesh 2
ES - Italia 2
FR - Francia 2
GB - Regno Unito 2
VE - Venezuela 2
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
TH - Thailandia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 650
Città #
Chandler 45
Naples 40
Princeton 31
Ashburn 28
Singapore 25
Munich 23
Hong Kong 19
Dong Ket 18
Turku 12
Brno 10
Dublin 10
Moscow 10
Nocera Inferiore 9
Sarno 9
Salerno 8
Domicella 6
Nuremberg 6
Pune 6
Boardman 5
Los Angeles 5
Ann Arbor 4
Dallas 4
Andover 3
Fisciano 3
Lappeenranta 3
Marano Di Napoli 3
Milan 3
Redwood City 3
Santa Clara 3
São Paulo 3
Toronto 3
Wilmington 3
Caserta 2
Chicago 2
Fairfield 2
Fremont 2
Guiyang 2
Helsinki 2
Monteforte Irpino 2
Mumbai 2
Novara 2
Pomigliano d'Arco 2
San Francisco 2
San Nicola la Strada 2
Seattle 2
Shanghai 2
Vienna 2
Alvorada d'Oeste 1
Andradas 1
Aparecida de Goiânia 1
Appleton 1
Araraquara 1
Atlanta 1
Bandeirantes 1
Barnaul 1
Beijing 1
Betim 1
Blainville 1
Borgo San Michele 1
Brasília 1
Brechin 1
Bury 1
Cabo Frio 1
Cachoeirinha 1
Cava De' Tirreni 1
Centereach 1
Cianorte 1
Council Bluffs 1
Curitiba 1
Dhaka 1
Dores de Campos 1
Dunedin 1
Duque de Caxias 1
Erbil 1
Fortaleza 1
Goiânia 1
Greenville 1
Groot-Brakrivier 1
Hanover 1
Houston 1
Ijuí 1
Islamabad 1
Itajaí 1
Jackson 1
Jinan 1
Jonesboro 1
Juiz de Fora 1
Jussara 1
Krasnodar 1
Latham 1
Liaocheng 1
Linhares 1
Manaus 1
Maracaibo 1
Maracaí 1
Marigliano 1
Montevideo 1
Montreal 1
Morada Nova 1
Nairobi 1
Totale 446
Nome #
Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. 93
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19 69
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 66
Sirt1 activity in pbmcs as a biomarker of different heart failure phenotypes 65
The role of pharmacogenetics for antithrombotic therapy management: new achievements and barriers yet to overcome 53
PD-L1 Dysregulation in COVID-19 Patients 47
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 47
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 46
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 39
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 31
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 30
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 29
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 27
Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature 27
Totale 669
Categoria #
all - tutte 3.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 2 13 13 3 4 2 0 18
2021/202267 6 0 2 2 9 1 0 1 5 0 16 25
2022/2023129 8 16 33 13 3 21 4 6 11 1 12 1
2023/202486 5 8 4 7 7 20 0 9 1 4 7 14
2024/2025321 12 8 8 13 14 16 82 25 48 20 45 30
2025/202611 11 0 0 0 0 0 0 0 0 0 0 0
Totale 669